Company / Interest Expense per Share
Aquestive Therapeutics, Inc. Interest Expense per Share History
FY2018-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.12
FY2023
5-year range
$0.12 / $0.32
FY2019-FY2023
Trend
-27.3%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense per Share has fluctuated over the past 6 years, ranging from $0.12 in FY2023 to $0.32 in FY2021.
Based on SEC 10-K filings.
0.12 in FY2023 with a 5-year CAGR of -17.8%.
Improved from $0.32 to $0.12 over the past 2 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -25.3%
- 5-Year CAGR
- -17.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, interest expense per share decreased 27.3% year-over-year.
- Peak interest expense per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.12 | -27.3% |
| FY2022 | $0.16 | -50.3% |
| FY2021 | $0.32 | +15.3% |
| FY2020 | $0.28 | -10.1% |
| FY2019 | $0.31 | +0.1% |
| FY2018 | $0.31 | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026